HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Manivannan Srinivasan Selected Research

Myocardial Infarction

11/2019Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.
1/2019Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
1/2018Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size.
1/2016Use of bioresorbable vascular scaffold: a meta-analysis of patients with coronary artery disease.
1/2015Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes.
3/2009Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Manivannan Srinivasan Research Topics

Disease

10Thrombosis (Thrombus)
11/2019 - 03/2009
7ST Elevation Myocardial Infarction
01/2020 - 02/2014
6Myocardial Infarction
11/2019 - 03/2009
4Acute Coronary Syndrome
02/2020 - 04/2006
2Hemorrhage
02/2020 - 01/2015
2Stroke (Strokes)
01/2020 - 11/2019
2Atrial Fibrillation
09/2019 - 11/2016
2Pain (Aches)
01/2018 - 01/2018
2Infarction (Infarctions)
01/2018 - 01/2018
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2017
1Thromboembolism
11/2016
1Fatigue
06/2011
1Insulin Resistance
04/2011
1von Willebrand Diseases (von Willebrand's Disease)
04/2006

Drug/Important Bio-Agent (IBA)

3Opiate AlkaloidsIBA
01/2020 - 01/2018
3Morphine (MS Contin)FDA LinkGeneric
01/2020 - 01/2018
3omega-Chloroacetophenone (Mace)IBA
11/2019 - 02/2014
2Biomarkers (Surrogate Marker)IBA
11/2019 - 04/2019
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2019 - 01/2018
1RivaroxabanIBA
02/2020
1Analgesics (Analgesic Drugs)IBA
01/2020
1C-Reactive ProteinIBA
11/2019
1apixabanIBA
09/2019
1FibrinIBA
04/2019
1Glutaral (Glutaraldehyde)IBA
04/2019
1Clopidogrel (Plavix)FDA Link
01/2019
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2019
1TicagrelorIBA
01/2019
1cangrelorIBA
01/2019
1TroponinIBA
01/2018
1Vitamin KFDA Link
11/2016
1AnticoagulantsIBA
11/2016
1Warfarin (Coumadin)FDA LinkGeneric
11/2016
1bivalirudin (Angiomax)FDA Link
01/2015
1Heparin (Liquaemin)FDA LinkGeneric
01/2015
1Glycoproteins (Glycoprotein)IBA
01/2015
1MetalsIBA
06/2011
1Triglycerides (Triacylglycerol)IBA
04/2011
1HDL LipoproteinsIBA
04/2011
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2011
1VLDL LipoproteinsIBA
04/2011
1Lipoproteins (Lipoprotein)IBA
04/2011
1von Willebrand FactorIBA
04/2006
1Proteins (Proteins, Gene)FDA Link
04/2006

Therapy/Procedure

9Percutaneous Coronary Intervention
01/2020 - 04/2006
5Therapeutics
02/2020 - 01/2018
5Stents
01/2018 - 06/2011
3Drug-Eluting Stents
12/2017 - 09/2010
2Drug Therapy (Chemotherapy)
02/2020 - 01/2019
2Analgesia
01/2018 - 01/2018
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
12/2017